Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 281

Altair lands NewFasant

Altair has picked up computational electromagnetics software developer NewFasant, based on the research of University of Alcalá associate professor Lorena Lozano Plata.

Jan 7, 2020

ETH Zurich yields 30 spinouts in 2019

ETH Zurich's portfolio attracted a record $649m in funding last year, and the university also spawned more businesses year-on-year.

Jan 7, 2020

Insight Partners imports Armis in $1.1bn deal

Insight Partners is acquiring the IoT security software provider through a transaction that will include $100m from Alphabet subsidiary CapitalG.

Jan 7, 2020

ECBF sees Brandkamp to general partner position

Michael Brandkamp has departed from its managing director role at corporate-backed fund HTGF to become a general partner European Circular Bioeconomy Fund.

Jan 7, 2020

Daily deal net: January 6, 2020

Today’s deal net captures the smaller investments from across the university innovation ecosystem over the past two weeks.

Jan 6, 2020

Oxford Nanopore sequences $38.5m

The University of Oxford DNA processing spinout tapped a consortium of unnamed investors in a round which also includes $106m in secondary funding.

Jan 6, 2020

Receipt Bank reaps $73m

Canadian Imperial Bank of Commerce contributed to the digital accounting platform developer's series C round, taking its total funding past $130m.

Jan 6, 2020

Oxford Nanopore extracts more funding

The Illumina and Amgen-backed genetic sequencing system developer raised $38.5m while its shareholders sold another $106m in shares.

Jan 6, 2020

Corporate venturing deal net: 23 December 2019-3 January 2020

In an extended version covering the holidays, Global Corporate Venturing has rounded up the period’s smaller deals and tracked the emerging companies accessing corporate funds.

Jan 3, 2020

Corporates sweeten $278m fund for Truffle Capital

Guerbet, Caisse Centrale de Réassurances, L’Occitane and Sopra Steria were among the backers for the life sciences-focused venture firm's BioMedTech fund.

Dec 23, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here